Compare TKNO & TRTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | TKNO | TRTX |
|---|---|---|
| Founded | 1996 | 2014 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 482.7M | 471.4M |
| IPO Year | 2021 | 2015 |
| Metric | TKNO | TRTX |
|---|---|---|
| Price | $9.00 | $6.02 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 8 | 6 |
| Target Price | $9.00 | ★ $9.88 |
| AVG Volume (30 Days) | 254.4K | ★ 985.5K |
| Earning Date | 11-05-2026 | 10-27-2026 |
| Dividend Yield | N/A | ★ 15.63% |
| EPS Growth | ★ 43.86 | N/A |
| EPS | N/A | ★ 0.19 |
| Revenue | ★ $40,520,000.00 | N/A |
| Revenue This Year | $13.53 | N/A |
| Revenue Next Year | $14.01 | $8.53 |
| P/E Ratio | ★ N/A | $33.37 |
| Revenue Growth | ★ 7.35 | N/A |
| 52 Week Low | $1.91 | $6.16 |
| 52 Week High | $9.48 | $9.37 |
| Indicator | TKNO | TRTX |
|---|---|---|
| Relative Strength Index (RSI) | 71.35 | 11.70 |
| Support Level | $4.87 | N/A |
| Resistance Level | $9.48 | $8.74 |
| Average True Range (ATR) | 0.53 | 0.18 |
| MACD | 0.06 | -0.08 |
| Stochastic Oscillator | 87.63 | 0.71 |
Alpha Teknova Inc is a producer of critical reagents for the discovery, development, and commercialization of novel therapies, vaccines, and molecular diagnostics. Its offer two primary product categories: Lab Essentials and Clinical Solutions. It derives key revenue from the United States. The company offers three primary product types: (i) pre-poured media plates for cell growth and cloning; (ii) liquid microbial culture media and supplements for cellular expansion; and (iii) molecular biology reagents for sample manipulation, resuspension, and purification.
TPG RE Finance Trust Inc is a commercial real estate finance company. It originates, acquires, and manages commercial mortgage loans and other commercial real estate-related debt instruments consisting of first mortgage loans and senior participation interests in first mortgage loans secured by institutional-quality properties in primary and select secondary markets in the United States. The company's objective is to provide attractive risk-adjusted returns to its stockholders over time through cash distributions and capital appreciation. It focuses on directly originating and selectively acquiring floating-rate first mortgage loans that are secured by high-quality commercial real estate properties undergoing some form of transition and value creation.